Xuying Huang

Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt/β-Catenin activity and cancer stemness

Rui Yan, Xiaona Fan, Zeru Xiao et al. · Cancer Letters · 2022 · 79 citations · Full text

Lung Adenocarcinoma, Immunology, Cancer Biology +19

Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma

Jiannan Yao, Ling Duan, Xuying Huang et al. · Frontiers in Oncology · 2021 · 36 citations · Full text

Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma

Yang Ge, Heshu Liu, Yuanyuan Zhang et al. · Translational Oncology · 2022 · 29 citations · Full text

Dclk1 Kinase, Immunology, T-cell Activity +16

Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling

Heshu Liu, Rui Yan, Zeru Xiao et al. · Breast Cancer Research · 2023 · 22 citations · Full text

A targetable MYBL2-ATAD2 axis governs cell proliferation in ovarian cancer

Qun Liu, Heshu Liu, Xuying Huang et al. · Cancer Gene Therapy · 2022 · 17 citations

Medicine, Tumor Suppressor, Radiation Oncology +4